Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Prostaglandins, Leukotrienes and Essential Fatty Acids

• Publication date

  1999-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1054/PLEF.1999.0038PMID 10509861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin C nutriture and risk of atherosclerotic heart disease.

  2009cited by this paper
• Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation.

  1998cited by this paper
• STUDY OF PLATELET‐ACTIVATING FACTOR ACETYLHYDROLASE IN THE PERIOPERATIVE PERIOD OF PATIENTS UNDERGOING CARDIAC SURGERY

  1998cited by this paper
• Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation.

  1998cited by this paper
• Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.

  1998cited by this paper
• Serum paraoxonase and platelet-activating factor acetylhydrolase in chronic renal failure.

  1998cited by this paper
• Vitamin E in der Therapie rheumatischer Erkrankungen

  1998cited by this paper
• A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis.

  1998cited by this paper
• [Vitamin E in therapy of rheumatic diseases].

  1998cited by this paper
• A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.

  1998cited by this paper
• Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: a prospective study

  1998cited by this paper
• Cardiopulmonary bypass primes polymorphonuclear leukocytes.

  1998cited by this paper
• Supersensitivity of atherosclerotic artery to constrictor effect of cigarette smoke extract.

  1998cited by this paper
• Vitamin E and atherosclerosis.

  1998cited by this paper
• Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers

  1997cited by this paper
• Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls.

  1997cited by this paper
• Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine.

  1997cited by this paper
• Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer

  1997cited by this paper
• Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.

  1997cited by this paper
• Lexipafant inhibits platelet activating factor enhanced neutrophil functions.

  1997cited by this paper
• Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein

  1997cited by this paper
• Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.

  1997cited by this paper
• Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram.

  1997cited by this paper
• Platelet-activating factor antagonists.

  1997cited by this paper
• Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury.

  1997cited by this paper
• Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.

  1997cited by this paper
• Leukocyte activation induces surface redistribution of P‐selectin glycoprotein ligand‐1

  1997cited by this paper
• Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses.

  1997cited by this paper
• Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation.

  1997cited by this paper
• [Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults].

  1996cited by this paper
• Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions.

  1996cited by this paper
• Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.

  1996cited by this paper
• Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis.

  1996cited by this paper
• PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.

  1996cited by this paper
• Platelet activating factor and endotoxin increase the enzyme activity and gene expression of type II phospholipase A2 in the rat intestine. Role of polymorphonuclear leukocytes.

  1996cited by this paper
• Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma.

  1996cited by this paper
• Release of histamine in whole blood by oxygen radicals: Division between specific and unspecific processes

  1996cited by this paper
• An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury.

  1996cited by this paper
• Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation

  1996cited by this paper
• A Novel Platelet Activating Factor Antagonist, SM-12502, Attenuates Endotoxin-induced Disseminated Intravascular Coagulation and Acute Pulmonary Vascular Injury by Inhibiting TNF Production in Rats

  1996cited by this paper
• Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.

  1996cited by this paper
• A rapid activation assay for human eosinophils based on adhesion to immobilized ICAM-1, VCAM-1 and IgG.

  1996cited by this paper
• Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock.

  1996cited by this paper
• The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia.

  1996cited by this paper
• Relative contribution of the de novo and remodelling pathways to the synthesis of platelet-activating factor in brain areas and during ischemia.

  1996cited by this paper
• Modulation of human platelet-activating factor receptor gene expression by protein kinase C activation.

  1996cited by this paper
• PAF and PAF acetylhydrolase in the nervous system.

  1996cited by this paper
• Hypoxia/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism.

  1996cited by this paper
• Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease.

  1996cited by this paper
• Enhanced expression of platelet-activating factor receptor on human eosinophils by interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor.

  1996cited by this paper
• Effect of a potent platelet-activating factor antagonist, WEB-2086, on asthma. A multicenter, double-blind placebo-controlled study in Japan.

  1996cited by this paper
• Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.

  1995cited by this paper
• Randomized, double‐blind phase II trial of Lexipafant, a platelet‐activating factor antagonist, in human acute pancreatitis

  1995cited by this paper
• Lymphocyte Adhesion to Human Endothelial Cells Induces Tissue Factor Expression via a Juxtacrine Pathway

  1995cited by this paper
• Oxidative stress in gastric mucosal injury: Role of platelet-activating factor-activated granulocytes

  1995cited by this paper
• Enhanced Association of Platelet-activating Factor Acetylhydrolase with Lipoprotein (a) in Comparison with Low Density Lipoprotein (*)

  1995cited by this paper
• Regulation of L‐selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone

  1995cited by this paper
• L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b/CD18) beta 2-integrin.

  1995cited by this paper
• Regulation of phospholipase A2 enzymes: selective inhibitors and their pharmacological potential.

  1995cited by this paper
• Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces.

  1995cited by this paper
• Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.

  1995cited by this paper
• Platelet-activating factor antagonists

  1995cited by this paper
• Cytokines and eicosanoids regulate PAF receptor gene expression.

  1995cited by this paper
• Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation.

  1995cited by this paper
• Treatment of rheumatoid arthritis with platelet activating factor antagonist BN 50730.

  1995cited by this paper
• Report on management of renal failure in Europe, XXIV, 1993.

  1995cited by this paper
• Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

  1995cited by this paper
• PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.

  1995cited by this paper
• Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion.

  1995cited by this paper
• Role of platelet activating factor in kidney transplant rejection in the rat.

  1995cited by this paper
• P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes.

  1995cited by this paper
• Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease.

  1995cited by this paper
• Platelet‐activating factor‐acetylhydrolase activity in maternal and umbilical venous plasma obtained from normotensive and hypertensive pregnancies

  1995cited by this paper
• Intraluminal excretion of PAF, lysoPAF, and acetylhydrolase in patients with ulcerative colitis

  1995cited by this paper
• Amelioration of experimental acute pancreatitis with a potent platelet‐activating factor antagonist

  1994cited by this paper
• IFN-gamma up-regulates platelet-activating factor receptor gene expression in human monocytes.

  1994cited by this paper
• 15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium.

  1994cited by this paper
• CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.

  1994cited by this paper
• New perspectives in hypertension research. Potentials of vascular biology.

  1994cited by this paper
• Platelet-activating factor mediates trinitrobenzene induced colitis.

  1994cited by this paper
• Oxidation of low density lipoprotein in patients on regular haemodialysis.

  1994cited by this paper
• The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.

  1994cited by this paper
• Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation.

  1994cited by this paper
• Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?

  1994cited by this paper
• Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.

  1994cited by this paper
• Platelet‐activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial

  1994cited by this paper
• Platelet-activating factor-acetylhydrolase activity in maternal and umbilical venous plasma obtained from normotensive and hypertensive pregnancies.

  1994cited by this paper
• Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.

  1993cited by this paper
• Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP.

  1993cited by this paper
• Platelet-Activating Factor–Induced Ischemic Bowel Necrosis: The Effect of Platelet-Activating Factor Acetylhydrolase

  1993cited by this paper
• Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin, and VLA-4 on human eosinophils and neutrophils.

  1993cited by this paper
• Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation.

  1993cited by this paper
• Platelet‐activating factor — acetylhydrolase activity in normotensive and hypertensive pregnancies

  1993cited by this paper
• Platelet‐Activating Factor Acetylhydrolase in Red Cell Membranes: Does Decreased Activity Impair Erythrocyte Deformability in Ischemic Stroke Patients?

  1993cited by this paper
• [Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass].

  1993cited by this paper
• Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages.

  1993cited by this paper
• Identification and functional characterization of platelet-activating factor receptors in human leukocyte populations using polyclonal anti-peptide antibody.

  1993cited by this paper
• Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.

  1993cited by this paper
• Juxtacrine intercellular signaling: another way to do it.

  1993cited by this paper
• Juxtacrine interactions of endothelial cells with leukocytes: tethering and signaling molecules.

  1993cited by this paper

• Efficacy and safety of edaravone combined with Ginkgo Leaf Extract and Dipyridamole in the treatment of acute cerebral infarction: A systematic review and meta-analysis

  2024cites this paper
• The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19

  2023cites this paper
• A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19

  2021cites this paper
• Kupffer Cell Release of Platelet Activating Factor Drives Dose Limiting Toxicities of Nucleic Acid Nanocarriers

  2020cites this paper
• Changes in preoperative and postoperative lipoprotein-associated phospholipase A2 activity in patients with malignant obstructive jaundice.

  2020cites this paper
• Progress in the Development of Platelet‐Activating Factor Receptor (PAFr) Antagonists and Applications in the Treatment of Inflammatory Diseases

  2018cites this paper
• Emerging roles of NudC family: from molecular regulation to clinical implications

  2016cites this paper
• Multicolor fluorescence nanoscopy by photobleaching: concept, verification, and its application to resolve selective storage of proteins in platelets.

  2014cites this paper
• Platelet-Activating Factor Receptor Blockade Ameliorates Aggregatibacter actinomycetemcomitans-Induced Periodontal Disease in Mice

  2013cites this paper
• cDNA Cloning and Expression Pattern of Homolog of Alpha Subunit of Platelet-Activating Factor Acetylhydrolase Ib from the Chinese Oak Silkworm, Antheraea pernyi

  2011cites this paper
• Activation of group VI phospholipase A2 isoforms in cardiac endothelial cells.

  2011cites this paper
• Platelet-Activating Factor Involvement in Thioacetamide-Induced Experimental Liver Fibrosis and Cirrhosis

  2010cites this paper
• The mammalian NudC-like genes: a family with functions other than regulating nuclear distribution

  2009cites this paper
• Blockades of phospholipase A(2) and platelet-activating factor receptors reduce the hemocyte phagocytosis in Rhodnius prolixus: in vitro experiments.

  2008cites this paper
• Dialysis-related systemic microinflammation is associated with specific genomic patterns.

  2008cites this paper
• Proteome analysis suggests that mitochondrial dysfunction in stressed endothelial cells is reversed by a soy extract and isolated isoflavones.

  2007cites this paper
• Platelet Activating Factor Acetylhydrolase의 대량 생산법 개발

  2006cites this paper
• Differences in Vascular Bed Disease Susceptibility Reflect Differences in Gene Expression Response to Atherogenic Stimuli

  2006cites this paper
• Lipoprotein-Associated Phospholipase A 2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial Coronary Heart Disease

  2006cites this paper
• WEB 2086, a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and hemocyte microaggregation reactions induced by Trypanosoma rangeli infection in Rhodnius prolixus hemolymph.

  2006cites this paper
• Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial

  2006cites this paper
• Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma.

  2006cites this paper
• cDNA cloning and expression of biologically active platelet activating factor-acetylhydrolase (PAF-AH) from bovine mammary gland.

  2005cites this paper
• Effet d'un hydroperoxyde lipidique et des LDL oxydées sur les enzymes impliquées dans la libération de l'acide arachidonique des phospholipides plaquettaires

  2004cites this paper
• Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity With Calcified Coronary Plaque in Young Adults: The CARDIA Study

  2004cites this paper
• Tea Polyphenols Inhibit Acetyl-CoA:1-Alkyl-sn-Glycero-3-Phosphocholine Acetyltransferase (a Key Enzyme in Platelet-Activating Factor Biosynthesis) and Platelet-Activating Factor-Induced Platelet Aggregation

  2004cites this paper
• Janus Kinase 2 Activation by the Platelet-Activating Factor Receptor (PAFR): Roles of Tyk2 and PAFR C Terminus1

  2003cites this paper
• Hemodynamic and proinflammatory actions of endothelin-1 in guinea pig small intestine submucosal microcirculation.

  2003cites this paper
• Age-related increase of plasma platelet-activating factor concentrations in Chinese.

  2003cites this paper
• Role of monocytes in atherogenesis.

  2003cites this paper
• Dissociation of the PAF‐receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium

  2002cites this paper
• Contribution of platelet activating factor to myocardial ischemia-reperfusion injury

  2002cites this paper
• Bioactive lipids and their receptors.

  2002cites this paper
• Prostaglandins and other lipid mediators in Alzheimer's disease.

  2002cites this paper
• Platelet activating factor‐induced apoptosis is inhibited by ectopic expression of the platelet activating factor G‐protein coupled receptor

  2002cites this paper
• Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2).

  2001cites this paper
• Could platelet activating factor play a role in developmental dyslexia?

  2001cites this paper
• PAF‐mediated Ca2+ influx in human neutrophils occurs via store‐operated mechanisms

  2001cites this paper
• The expanding superfamily of phospholipase A(2) enzymes: classification and characterization.

  2000cites this paper
• Platelet-activating factor acetylhydrolases in health and disease.

  2000cites this paper
• Neuroinflammatory Signaling Upregulation in Alzheimer's Disease

  2000cites this paper
• Multicolor Fluorescence Nanoscopy by Photobleaching – Concept Verification and Its Application to Resolve Selective Storage of Proteins in Platelets

  year unknowncites this paper